Tenet’s ambulatory business, United Surgical Partners International, “continues to deliver” for the Dallas-based system, Chairman and CEO Saum Sutaria, MD, said on the Dallas-based system’s July 22 earnings call.
USPI’s second-quarter 2025 net operating revenue increased 11.3% year over year to $1.3 billion, according to its financial report. Tenet attributed the increase to strong net revenue per-case growth, facility acquisitions and increased service lines.
Dr. Sutaria said USPI added eight facilities in the second quarter, including facilities specializing in high acuity procedures such as spine, orthopedics and neurosurgery.
“We continue to see a robust pipeline for M&A opportunities and expect to exceed our baseline intention for $250 million of M&A spend in 2025,” he said.
Tenet raised its 2025 outlook after posting an operating income of $832 million (15.6% operating margin) and a net income of $288 million in the second quarter. The system is now projecting an adjusted net income of $1.12 billion to $1.22 billion in 2025, up from the previous estimate of $1 billion to $1.2 billion.
For USPI, Tenet is now expecting net operating revenues between $5 billion and $5.15 billion for the year. Previously, the ambulatory segment was projected to generate between $4.9 billion and $5 billion in net operating revenues.
